Rxcurve
HCPCS J8522 · per 50 MG

Capecitabine, oral, 50 mg

Products billed under this code include Capecitabine, Xeloda.

Payment limit per 50 MG, by effective quarter, 4Q24 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.

Products billed under J8522

From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.

ProductLabelerNDCUnits / pkgLimit / pkg
Capecitabine Genentech, Inc. 00004-1101-50 1200 $34.80
Capecitabine Teva Pharmaceuticals USA, Inc. 00093-7473-06 180 $5.22
Capecitabine Teva Pharmaceuticals USA, Inc. 00093-7474-89 1200 $34.80
Capecitabine Accord Healthcare Inc 16729-0072-12 180 $5.22
Capecitabine Accord Healthcare Inc 16729-0073-29 1200 $34.80
Capecitabine Dr. Reddy's Laboratories Inc. 55111-0496-60 180 $5.22
Capecitabine Dr. Reddy's Laboratories Inc. 55111-0497-04 1200 $34.80
Capecitabine Aurobindo Pharma Usa, Inc. 59651-0204-60 180 $5.22
Capecitabine Aurobindo Pharma Usa, Inc. 59651-0205-08 1200 $34.80
Capecitabine American Health Packaging 60687-0149-94 200 $5.80
Show all 25 products
ProductLabelerNDCUnits / pkgLimit / pkg
Capecitabine Ascend Laboratories, LLC 67877-0458-60 180 $5.22
Capecitabine Ascend Laboratories, LLC 67877-0459-12 1200 $34.80
Capecitabine BluePoint Laboratories 68001-0487-06 180 $5.22
Capecitabine BluePoint Laboratories 68001-0488-07 1200 $34.80
Capecitabine BluePoint Laboratories 68001-0643-06 180 $5.22
Capecitabine BluePoint Laboratories 68001-0644-07 1200 $34.80
Capecitabine Cipla USA, Inc. 69097-0948-08 1200 $34.80
Capecitabine Cipla USA, Inc. 69097-0949-03 180 $5.22
Capecitabine Lifestar Pharma 70756-0815-60 180 $5.22
Capecitabine Lifestar Pharma 70756-0816-22 1200 $34.80
Capecitabine Novadoz Pharmaceuticals LLC 72205-0006-60 180 $5.22
Capecitabine Novadoz Pharmaceuticals LLC 72205-0007-92 1200 $34.80
Capecitabine Quallent Pharmaceuticals 82009-0112-12 1200 $34.80
Xeloda Genentech, Inc. 00004-1100-20 180 $5.22
Xeloda H2 Pharma LLC 61269-0470-60 180 $5.22

Every quarter

QuarterPayment limitChangeBilling unitDescriptionSource file
4Q26 $0.029 −$0.051 50 MG Capecitabine, oral, 50 mg v1, posted September 17, 2026
3Q26 $0.08 +$0.05 50 MG Capecitabine, oral, 50 mg v1, posted September 15, 2026
2Q26 $0.03 −$0.008 50 MG Capecitabine, oral, 50 mg v1, posted September 15, 2026
1Q26 $0.038 +$0.001 50 MG Capecitabine, oral, 50 mg v1, posted September 15, 2026
4Q25 $0.037 −$0.016 50 MG Capecitabine, oral, 50 mg v1, posted September 8, 2026
3Q25 $0.053 −$0.012 50 MG Capecitabine, oral, 50 mg v1, posted March 10, 2026
2Q25 $0.065 +$0.025 50 MG Capecitabine, oral, 50 mg v1, posted March 10, 2026
1Q25 $0.04 −$0.024 50 MG Capecitabine, oral, 50 mg v1, posted December 19, 2025
4Q24 $0.064 – 50 MG Capecitabine, oral, 50 mg v1, posted June 11, 2025

“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.

CMS source files